Results 221 to 230 of about 158,050 (340)
Temporary RVAD support following HM3 LVAD is associated with high morbidity and mortality. Temporary RVAD support occurs most frequently in INTERMACS 1 or 2 patients and those who require pre‐operative VA‐ECMO. In addition to higher post‐operative mortality, a significantly higher risk of both dialysis and stroke at 1 year post‐implant was observed in ...
Vinh Q. Chau+12 more
wiley +1 more source
Off-pump total arterial bypass grafting for the elderly does not improve life expectancy. [PDF]
Arayawudhikul N+9 more
europepmc +1 more source
Dacron femoropopliteal bypass grafts
R. C. Kester+3 more
openaire +3 more sources
Abstract Background and aims The pulmonary artery pulsatility index (PAPi), that is, the pulmonary artery pulse pressure (PAPP) divided by the mean right atrial pressure (mRAP), is an increasingly used invasive index of right ventricular function. We sought to assess the prognostic impact of the PAPi in unselected patients with aortic stenosis (AS ...
Laura A. Rechsteiner+9 more
wiley +1 more source
Chronic Total Occlusion Revascularization Strategies: A Comparative Study of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting. [PDF]
Liu Y, Wang S, Peng H, Fan Q, Liu J.
europepmc +1 more source
Circumflex Coronary Artery Bypass Grafting Via Transverse Sinus
Allen S. Hudspeth
openalex +2 more sources
Abstract Aims A cardiovascular magnetic resonance (CMR) approach to non‐invasively estimate left ventricular (LV) filling pressure was recently developed and shown to correlate with invasively measured pulmonary capillary wedge pressure (PCWP). We examined the association between CMR‐estimated PCWP (CMR‐PCWP) and other imaging and biomarker measures of
Joanna Osmanska+11 more
wiley +1 more source
Postoperative predictive value of a new method of intraoperative angiographic assessment of runoff in femoropopliteal bypass grafting [PDF]
Sadettin Karacagil+4 more
openalex +1 more source
Baseline characteristics for the vericiguat global study in participants with chronic heart failure (VICTOR) trial. ARNI, angiotensin receptor/neprilysin inhibitor; CRT, cardiac resynchronization therapy; eGFR, estimated glomerular filtration rate; GDMT, guideline‐directed medical therapy; HF, heart failure; HFrEF, heart failure with reduced ejection ...
Clara I. Saldarriaga+21 more
wiley +1 more source